IASO Biotherapeutics and Innovent Biologics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress
PLEASANTON, Calif. & NANJING, China--(BUSINESS WIRE)--#AutoimmuneDiseases--IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in…